VidaPeps logo
AX-2026-3622-RBMAv7
SS-31 · Lot SS-50MG-260622-3P · VidaPeps
CRYPTOGRAPHICALLY SEALED
SHA-384: 076d5c53c9ef7f16
Scan to verify
PRODUCT ATTRIBUTION
VidaPeps logo
VidaPeps
VidaPeps LLC
vidapeps.com
Brand identity verified
Submitted by: VidaPeps LLC

Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
PASS — All specifications met4 of 4 layers complete
  • L1
    Identity
  • L2
    Purity
  • L3
    Net Peptide Content
  • L4
    Sterility Screen
SAMPLE & VIAL VALIDATION
BrandVidaPeps
ProductSS-31
Lot / BatchSS-50MG-260622-3P
Label Claim50 mg lyophilized powder
Matrixlyophilized powder
Sample Count3
Cap ColorRoyal Blue
Crimp ColorSilver / Aluminum
Contents ColorWhite
Seal IntactYes
Conditionsealed, intact

Test Results

Select a test for its full result
Referencewithin ±1 Da of 639.802 DaResult639.6 Da (error -0.202 Da)PASS
Referenceat least 98% (Axiom 4X Essential purity limit >= 98.0% by RP-HPLC at 214 nm (USP <621>))Result99.05%PASS
Referencewithin ±10% of 50 mg and CV at or below 5%Resultmean 50.67 mg over 3 vials, CV 0.58%PASS
ReferenceUSP <71>ResultNo GrowthPASS

REPORTING SCOPE & LIMITATIONS

  • [Purity]A single main component peak is on record for this certificate; a full impurity profile was not retained.
REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:22a4152a647b1851b1aa22f4...
Technical Reviewer
Michael Niles
ed25519:289642b77a929c47e729b72d...
Laboratory Director
Daniel Brennan
ed25519:553844628d18e1af5fd9a69d...
Released Jul 1, 2026, 05:03 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-3622-RBMA
REPORTING SCOPE

Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.

RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

ANALYSIS & ACCREDITATION

Physical instrument analysis is performed within Axiom Analytics' laboratory network, allocated at Axiom's discretion based on method, capacity, and order volume. Axiom Analytics performs sample accession, chain of custody, analytical oversight, and data review, and issues and is responsible for this certificate. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: samples are analyzed under double-blind conditions, identified only by an internal lot ID.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.